title: [Effect of metabolizable peptide p16INK4a on short-lived human tumor cultures].
abstract: The study was concerned with antitumor action of internalized peptide incorporating a fragment of p161INK4a using a model of short-lived human tumor cultures sampled from resected material. Renal cancer sample showed the greatest therapeutic interval.
authors: V K
authors: VK
authors: Bozhenko
authors: T M
authors: TM
authors: Kulinich
authors: A V
authors: AV
authors: Ivanov
authors: E A
authors: EA
authors: Kudinova
authors: A M
authors: AM
authors: Shishkin
authors: V P
authors: VP
authors: Kharchenko
mesh_terms: D000970:Antineoplastic Agents / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D013997:Time Factors; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; D019941:Cyclin-Dependent Kinase Inhibitor p16